Associated Papers
Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance.
Raaijmakers MI et al.
Oncotarget, 2016
27791198 (PubMed )
Supplement: oncotarget-07-77163-s002.xlsx › Patient_2_late_met_4
Integrative analysis of mutational and transcriptional profiles reveals driver mutations of metastatic breast cancers.
Lee JH et al.
Cell Discovery, 2016
27625789 (PubMed )
Supplement: celldisc201625-s8.pdf
Select a paper to view details